BIOMARIN PHARMACEUTICAL INC Quarterly Other Assets, Current in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Biomarin Pharmaceutical Inc quarterly Other Assets, Current history and growth rate from Q2 2010 to Q2 2024.
  • Biomarin Pharmaceutical Inc Other Assets, Current for the quarter ending June 30, 2024 was $160M, a 17% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $160M -$33M -17% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $163M -$9.89M -5.71% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $141M +$36.9M +35.3% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 $225M +$75M +50% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $193M +$54.4M +39.1% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $173M +$51.9M +42.8% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $105M -$5.92M -5.36% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $150M +$42.1M +39.1% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $139M +$40M +40.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $121M +$30M +32.9% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $110M -$19.5M -15% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $108M -$13M -10.8% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $99M -$43.1M -30.3% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $91.2M -$64.6M -41.4% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $130M -$723K -0.55% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $121M -$5.8M -4.58% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $142M +$22.3M +18.7% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $156M +$61.9M +66% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $131M +$32.3M +32.8% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $127M +$54.9M +76.6% Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 $120M +$39.7M +49.6% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $93.9M +$22.1M +30.8% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $98.4M +$24.4M +32.9% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $71.7M -$12M -14.3% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $80.1M +$17.2M +27.4% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $71.8M +$11.4M +18.9% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $74M +$12.3M +20% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $83.6M +$15.2M +22.3% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $62.9M +$930K +1.5% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $60.3M +$2.13M +3.67% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $61.7M +$1.33M +2.2% Dec 31, 2016 10-K 2018-02-26
Q3 2016 $68.4M -$46.9M -40.7% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $61.9M -$15.6M -20.1% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $58.2M -$26.1M -30.9% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 $60.4M -$48.1M -44.4% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $115M +$58.9M +104% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $77.6M +$40.3M +108% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $84.3M +$43.3M +105% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $109M +$66.8M +160% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $56.5M +$28.3M +100% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 $37.3M +$3.74M +11.2% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $41M +$5.51M +15.5% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $41.7M +$16.2M +63.5% Dec 31, 2013 10-K 2015-03-02
Q3 2013 $28.2M -$26.7M -48.6% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 $33.5M -$24.5M -42.3% Jun 30, 2013 10-Q 2013-07-29
Q1 2013 $35.5M -$15M -29.7% Mar 31, 2013 10-Q 2013-04-29
Q4 2012 $25.5M +$6.87M +36.9% Dec 31, 2012 10-K 2014-02-26
Q3 2012 $54.8M +$14.9M +37.2% Sep 30, 2012 10-Q 2012-10-29
Q2 2012 $58.1M +$21.8M +60% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 $50.5M +$15.5M +44.4% Mar 31, 2012 10-Q 2012-04-30
Q4 2011 $18.6M -$15.2M -45% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $40M +$8.22M +25.9% Sep 30, 2011 10-Q 2011-10-31
Q2 2011 $36.3M +$13.5M +59.3% Jun 30, 2011 10-Q 2011-08-01
Q1 2011 $35M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 $33.9M Dec 31, 2010 10-K 2012-02-22
Q3 2010 $31.7M Sep 30, 2010 10-Q 2010-10-29
Q2 2010 $22.8M Jun 30, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.